Monday, October 23, 2017
Well, we've come to the end of the 1st quarter and it has ended with a bang. As of today, the Select Portfolio is up over 30% since inception with the average stock up 20%. This is the result...
Tailwinds' Take: in the case of RESN the numbers are meaningless and it's all in the guidance. On that front, Resonant has knocked it out of the park. To quote the CEO, "we are confident our technology, tools and...
Tailwinds' Take: while not a huge milestone, this is another step forward towards full FDA product approval. 3DS is proving, with every positive result, that they are developing the most effective diagnostic tools in the industry. WINNIPEG, Manitoba, March 29,...
In this article I discuss a Lithium (“Li”) junior that has successfully locked down, via option agreements, several key lithium properties / projects in Chile (mgmt. still looking for more) and owns or controls 4 precious / base metal projects...
As of this morning, at $2.09 per share, we have added Cryoport (CYRX) to the Tailwinds Select Portfolio. Cryoport is in the business of shipping medicines. Any biologic that needs to be cryogenically suspended until it is dosed into a...
SPX Monitoring purposes;  Long SPX on 3/24/17 at 2343.98. Monitoring purposes GOLD: Sold GDX at 24.33 on 2/22/07 = gain 20.15%; Long GDX on 12/28/16 at 20.25. Long Term Trend monitor purposes: Covered short SPX on 3/24/17 at 2343.98: Short SPX...
Tailwinds' Take: This transaction will provide the needed cash to see CYRX through to cash-flow positive, an event that will happen in either the last Q of this year or first of next. Once this transaction closes, I believe...
The end of the first quarter always coincides with the end of March Madness. The frenzied first two weeks of the NCAA tournament are over and we are down to only 8 teams remaining. These teams have all positioned...
Tailwinds' Take: all eyes are on execution of this plan, which, if achieved, will establish them as the market leader in AR. Can they ramp production and make sales? Can they get their margins over 40%? Can they announce...
Tailwinds' Take: One of many potential applications for 3DS's diagnostic abilities. Alzheimer's represents a potential home run market for TeloView™. Announcement of a partner on this disease shouldn't be too far off and will be a big catalyst. WINNIPEG, MB...
Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address